Background: Dietary sources of α-linolenic acid, such as perilla seed oil, may have the capacity to inhibit the generation of leukotrienes (LTs) by leucocytes in patients with asthma, as has been reported with the consumption of other long-chain n-3 fatty acids. Methods: The factors affecting the suppression of leukotriene (LT) C4 generation by leucocytes were examined by comparing the clinical features of patients with asthma who had been given dietary perilla seed oil (n-3 fatty acids). Group A consisted of patients in whom the leucocyte generation of LTC4 was suppressed by dietary perilla seed oil. Group B consisted of those in whom LTC4 generation was not suppressed. Results: LTC4 generation by leucocytes decreased significantly in group A after 2 (p < 0.05) and 4 weeks (p < 0.05); conversely, it increased significantly in group B after 4 weeks (p < 0.05). The two study groups differed significantly in terms of LTC4 generation by leucocytes after 4 weeks of dietary supplementation (p < 0.05). Ventilatory parameters such as peak expiratory flow (PEF), forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) increased significantly after 4 weeks of dietary supplementation in group A (p < 0.05). Values of PEF, FVC, FEV1 and maximum expiratory flow at 25% of the forced vital capacity (v̇25) differed significantly between groups A and B prior to dietary supplementation. Serum levels of total cholesterol, low-density lipoprotein (LDL) cholesterol and phospholipid were significantly decreased by dietary supplementation in group A after 4 weeks. Serum levels of total cholesterol, triglyceride, high-density lipoprotein cholesterol, LDL cholesterol and phospholipid differed significantly between the two study groups prior to dietary supplementation. Serum levels of triglyceride and LDL cholesterol differed significantly between the two study groups after 4 weeks of dietary supplementation. Conclusions: Dietary supplementation with perilla seed oil in selected patients with asthma suppresses the generation of LTC4 and is associated with clinical features such as respiratory function and lipometabolism.

1.
Guidelines for the Diagnosis and Management of Asthma: Expert Panel Report 2, NIH publication no 97–4051. Bethesda, National Institutes of Health, 1997.
2.
Holgate S: Mediator and cytokine mechanisms in asthma. Thorax 1993;48:103–109.
3.
Kaliner M, Eggleston PA, Mathews KP: Rhinitis and asthma. JAMA 1987;258:2851–2871.
4.
Dahlen SE, Hedqvist P, Hammarstrom S, Samuelsson B: Leukotrienes are potent constrictors of human bronchi. Nature 1980;288:484–486.
5.
Chagnon M, Gentile J, Gladu M, Sirois P: The mechanism of action of leukotrienes A4, C4 and D4 on human lung parenchyma in vitro. Lung 1985;163:55–62.
6.
Henderson WR Jr: Role of leukotrienes in asthma. Ann Allergy 1994;72:272–278.
7.
Weller PF, Lee CW, Foster DW, Corey EJ, Austen KF, Lewis RA: Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: Predominant production of LTC4. Proc Natl Acad Sci USA 1983;80:7626–7630.
8.
Peters SP, MacGlashan DW, Schulman ES, Schleimer RP, Hayes EC, Rokach J, Adkinson NF Jr, Lichtenstein LM: Arachidonic acid metabolism in purified human lung mast cells. J Immunol 1984;132:1972–1979.
9.
Mitsunobu F, Mifune T, Hosaki Y, Ashida K, Yokota S, Tsugeno H, Tanizaki Y: Different roles of histamine and leukotriene C4 in the airways between patients with atopic and nonatopic asthma. J Asthma 1998;35:367–372.
10.
Thien FC, Walters EH: Eicosanoids and asthma: An update. Prostaglandins Leukot Essent Fatty Acids 1995;52:271–288.
11.
Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Kecskemeti K, Gramlich TL, Beeken W: Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992;116:609–614.
12.
Ikehata A, Hiwatashi N, Kinouchi Y, Yamazaki H, Kumagai Y, Ito K, Kayaba Y, Toyota T: Effect of intravenously infused eicosapentaenoic acid on the leukotriene generation in patients with active Crohn’s disease. Am J Clin Nutr 1992;56:938–942.
13.
Lau CS, Morley KD, Belch JJ: Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis – a double-blind placebo controlled study. Br J Rheumatol 1993;32:982–989.
14.
Nielsen GL, Faarvang KL, Thomsen BS, Teglbjaerg KL, Jensen LT, Hansen TM, Larvang HH, Schmidt EB, Dyerberg J, Ernst E: The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: A randomized, double blind trial. Eur J Clin Invest 1992;22:687–691.
15.
Kojima T, Terano T, Tanabe E, Okamoto S, Tamura Y, Yoshida S: Long-term administration of highly purified eicosapentaenoic acid provides improvement of psoriasis. Dermatologica 1991;182:225–230.
16.
Mayser P, Mrowietz U, Arenberger P, Bartak P, Buchvald J, Christophers E, Jablonska S, Salmhofer W, Schill WB, Kramer HJ, Schlotzer E, Mayer K, Seeger W, Grimminger F: Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol 1998;38:539–547.
17.
Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH: Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 1988;43:84–92.
18.
Arm JP, Horton CE, Spur BW, Mencia-Huerta JM, Lee TH: The effects of dietary supplementation with fish oil lipids on the airways response to inhaled allergen in bronchial asthma. Am Rev Respir Dis 1989;139:1395–1400.
19.
Dry J, Vincent D: Effect of a fish oil diet on asthma: Results of a 1-year double-blind study. Int Arch Allergy Appl Immunol 1991;95:156–157.
20.
Thien FC, Mencia-Huerta JM, Lee TH: Dietary fish oil effects on seasonal hay fever and asthma in pollen-sensitive subjects. Am Rev Respir Dis 1993;147:1138–1143.
21.
Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM: Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr 1997;65:1011–1017.
22.
von Schacky C, Kiefl R, Jendraschak E, Kaminski WE: n-3 fatty acids and cysteinyl-leukotriene formation in humans in vitro, ex vivo and in vivo. J Lab Clin Med 1993;121:302–309.
23.
Picado C, Castillo JA, Schinca N, Pujades M, Ordinas A, Coronas A, Agusti-Vidal A: Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: A pilot study. Thorax 1988;43:93–97.
24.
Stenius-Aarniala B, Aro A, Hakulinen A, Ahola I, Seppala E, Vapaatalo H: Evening primrose oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Ann Allerg 1989;62:534–537.
25.
Ashida K, Mitsunobu F, Mifune T, Hosaki Y, Yokota S, Tsugeno H, Tanizaki Y: A pilot study: Effect sof dietary supplementation with α-linolenic acid-enriched perilla seed oil on bronchial asthma. Allergol Intern 1997;46:181–185.
26.
International consensus report on diagnosis and treatment of asthma. National Heart, Lung, and Blood Institute, National Institutes of Health. Bethesda, Maryland 20982. Publication no. 92-3091, March 1992. Eur Respir J 1992;5:601–641.
27.
Rautela GS, Liedtke RJ: Automated enzymic measurement of total cholesterol in serum. Clin Chem 1978;24:108–114.
28.
Tietz NW: Textbook of Clinical Chemistry. Philadelphia, Saunders, 1986, pp 52–53, 487–497.
29.
Shimizu S, Yasui K, Tani Y, Yamada H: Acyl-CoA oxidase from Candida tropicalis. Biochem Biophys Res Commun 1979;91:108–113.
30.
Takayama M, Itoh S, Nagasaki T, Tanimizu L: A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 1977;79:93–98.
31.
Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499–509.
32.
Tanizaki Y, Kitani H, Okazaki M, Mifune T, Mitsunobu F, Kimura I: Changes in the proportions of bronchoalveolar lymphocytes, neutrophils and basophilic cells and the release of histamine and leukotrienes from bronchoalveolar cells in patients with steroid-dependent intractable asthma. Int Arch Allergy Immunol 1993;101:196–201.
33.
Jemionek JF, Contreras TJ, French JE, Shields LJ: Technique for increased granulocyte recovery from human whole blood by counterflow centrifugation elutriation. 1. In vitro analyses. Transfusion 1979;19:120–128.
34.
Tanizaki Y, Sudo M, Kitani H, Kawauchi K, Mifune T, Takahashi K, Kimura I: Release of heparin-like substance and histamine from basophilic leukocytes separated by counterflow centrifugation elutriation. Jpn J Med 1990;29:356–361.
35.
Lam S, Chan H, LeRiche JC, Chan-Yeung M, Salari H: Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol 1988;81:711–717.
36.
Taniguchi Y, Tamura G, Honma M, Aizawa T, Maruyama N, Shirato K, Takishima T: The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. J Allergy Clin Immunol 1993;92:507–512.
37.
Hamilton AL, Watson RM, Wyile G, O’Byrne PM: Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx1005. Thorax 1997;52:348–354.
38.
Egusa G, Murakami F, Ito C, Matsumoto Y, Kado S, Okamura M, Mori H, Yamane K, Hara H, Yamakido M: Westernized food habits and concentrations of serum lipids in the Japanese. Atherosclerosis 1993;100:249–255.
39.
Garg ML, Cladinin MT: Alpha-linolenic acid and metabolism of cholesterol and long-chain fatty acids. Nutrition 1992;8:208–210.
40.
Ikeda I, Mitsui K, Imaizumi K: Effect of dietary linoleic, alpha-linolenic and arachidonic acids on lipid metabolism, tissue fatty acid composition and eicosanoid production in rats. J Nutr Sci Vitaminol (Tokyo) 1996;42:541–551.
41.
Ikeda I, Cha JY, Yanagita T, Nakatani N, Oogami K, Inaizumi K, Yazawa K: Effects of dietary alpha-linolenic, eicosapentaenoic and docosahexaenoic acids on hepatic lipogenesis and beta-oxidation in rats. Biosci Biotechnol Biochem 1998;62:675–680.
42.
Prasad K, Mantha SV, Muir AD, Westcott ND: Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 1998;136:367–375.
43.
Larsson-Backstrom C, Lindmark L, Svensson L: Effects of dietary alpha- and gamma-linolenic acids on liver fatty acids, lipid metabolism, and survival in sepsis. Shock 1995;4:11–20.
44.
Koga T, Nonaka M, Gu JY, Sugano M: Linoleic and alpha-linolenic acids differently modify the effects of elaidic acid on polyunsaturated fatty acid metabolism and some immune indices in rats. Br J Nutr 1997;77:645–656.
45.
Seppanen-Laakso T, Vanhanen H, Laakso I, Kohtamaki H, Viikari J: Replacement of butter on bread by rapeseed oil and rapeseed oil-containing margarine: Effects on plasma fatty acid composition and serum cholesterol. Br J Nutr 1992;68:639–654.
46.
Mensink RP, Katan MB: Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med 1989;321:436–441.
47.
Damon M, Chavis C, Crastes de Paulet A, Michel FB, Godard P: Arachidonic acid metabolism in alveolar macrophages. A comparison of cells from healthy subjects, allergic asthmatics, and chronic bronchitis patients. Prostaglandins 1987;34:291–309.
48.
Gu JY, Wakizono Y, Dohi A, Nonaka M, Sugano M, Yamada K: Effect of dietary fats and sesamin on the lipid metabolism and immune function of Sprague-Dawley rats. Biosci Biotechnol Biochem 1998;62:1917–1924.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.